Bacterial adhesion interfaces on the skin surface

Bacterial adhesion interfaces on the skin surface are the molecular contact zones where microbial adhesins interact with host cell receptors or extracellular matrix (ECM) components to initiate colonization (Foster et al., 2014, PMID: 24931194). These interfaces primarily involve Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), such as fibronectin-binding proteins and clumping factors, which anchor bacteria like Staphylococcus aureus to host ligands including keratin, collagen, and fibronectin (Grice & Segre, 2011, PMID: 21407241). This initial attachment is a prerequisite for biofilm formation and subsequent tissue invasion, playing a central role in the pathogenesis of skin and soft tissue infections, atopic dermatitis, and chronic wound complications (Otto, 2010, PMID: 20442824). Therapeutic targeting of these interfaces, known as anti-adhesion therapy, utilizes monoclonal antibodies, synthetic peptides, or small molecules to competitively inhibit these interactions (Krachler & Orth, 2013, PMID: 23406778). By preventing the physical attachment of pathogens without exerting direct bactericidal pressure, these strategies offer a potential means to manage infections while minimizing the development of antimicrobial resistance.

Other names

Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs)Bacterial-host cell adhesionSkin-microbe interfaceBacterial attachment sites

Competitive inhibition of bacterial adhesins binding to host cell receptors or extracellular matrix proteins, preventing initial colonization and subsequent biofilm formation (Krachler & Orth, 2013, PMID: 23406778).